Longer life expectancy, aging population necessitate new strategies for prostate cancer care
December 4, 2012 · Comments Off
Members of the University of Colorado Cancer Center recently published a review in the journal Drugs and Aging describing the modern state of prostate cancer care – examining not only new drugs but entirely new classes of drugs that may be effective and well-tolerated in our aging population.
Study identifies human melanoma stem cells
August 23, 2012 · Comments Off
Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed...
University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
August 15, 2012 · Comments Off
Bladder cancer kills by metastasizing – usually to the lungs. A major grant from the...
Human tumors grown in mice help little cancer drugs go big
May 2, 2012 · Comments Off
THREE KEY POINTS: Human tumors, sampled and grown on mice are more accurate cancer models...
Phase I trial of promising anti-cancer drug CUDC-101 opens with first patient treated at CU Cancer Center
August 18, 2011 · Comments Off
The University of Colorado Cancer Center has treated the first patient with a promising cancer-fighting...
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu enzalutamide fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
How did you celebrate Dress In Blue Day? #CRCSMhttp://ow.ly/KKJDd http://t.co/ULMLhnayyQ